Report cover image

Albumin (as Excipient) Market (Product Type: Human Serum Albumin and Recombinant Albumin; and Application: Human Serum Albumin and Recombinant Albumin) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Publisher Transparency Market Research Pvt. Ltd.
Published Jun 29, 2022
Length 200 Pages
SKU # TNPR17331026

Description

Albumin (as Excipient) Market (Product Type: Human Serum Albumin and Recombinant Albumin; and Application: Human Serum Albumin and Recombinant Albumin) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Albumin (as Excipient) Market – Scope of Report
TMR’s report on the global albumin (as excipient) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global albumin (as excipient) market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global albumin (as excipient) market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the albumin (as excipient) market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global albumin (as excipient) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global albumin (as excipient) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global albumin (as excipient) market.

The report delves into the competitive landscape of the global albumin (as excipient) market. Key players operating in the global albumin (as excipient) market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global albumin (as excipient) market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market albumin (as excipient).

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

Table of Contents

200 Pages
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Albumin (as Excipient) Market Forecast
4.4. Global Albumin (as Excipient) Market Outlook
5. Market Outlook
5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.2. Technological Advancement
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type
6.1. Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type
6.2. Introduction
6.3. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
6.4. Global Albumin (as Excipient) Market Forecast, by Product Type
6.4.1. Human Serum Albumin
6.4.2. Recombinant Albumin
6.5. Global Albumin (as Excipient) Market Analysis, by Product Type
7. Global Albumin (as Excipient) Market Analysis and Forecast, by Application
7.1. Introduction
7.2. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
7.3. Global Albumin (as Excipient) Market Forecast, by Application
7.3.1. Human Serum Albumin Applications
7.3.1.1. Drug Formulation
7.3.1.2. Drug Delivery
7.3.1.3. Vaccines
7.3.1.4. Medical Device Coating
7.3.1.5. Culture Medium & Stabilizer
7.3.1.6. Diagnostics
7.3.1.7. In Vitro Fertilization
7.3.2. Recombinant Albumin
7.3.2.1. Drug Formulation
7.3.2.2. Drug Delivery
7.3.2.3. Vaccines
7.3.2.4. Medical Device Coating
7.3.2.5. Culture Medium & Stabilizer
7.3.2.6. Diagnostics
7.3.2.7. In Vitro Fertilization
7.4. Global Albumin (as Excipient) Market Analysis, by Application
8. Global Albumin (as Excipient) Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
8.3. Global Albumin (as Excipient) Market Forecast, by End-user
8.3.1. Pharmaceutical & Biotechnology Industry
8.3.2. Research Institutes
8.3.3. Others
8.4. Global Albumin (as Excipient) Market Analysis, by End-user
9. Global Albumin (as Excipient) Market Analysis and Forecast, by Region
9.1. Global Albumin (as Excipient) Market Analysis, by Region
9.2. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Region
9.3. Global Albumin (as Excipient) Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Albumin (as Excipient) Market Analysis
10.1. North America Albumin (as Excipient) Market Overview
10.2. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Country
10.3. North America Albumin (as Excipient) Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
10.5. North America Albumin (as Excipient) Market Forecast, by Product Type
10.5.1. Human Serum Albumin
10.5.2. Recombinant Albumin
10.6. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
10.7. North America Albumin (as Excipient) Market Forecast, by Application
10.7.1. Human Serum Albumin Applications
10.7.1.1. Drug Formulation
10.7.1.2. Drug Delivery
10.7.1.3. Vaccines
10.7.1.4. Medical Device Coating
10.7.1.5. Culture Medium & Stabilizer
10.7.1.6. Diagnostics
10.7.1.7. In Vitro Fertilization
10.7.2. Recombinant Albumin
10.7.2.1. Drug Formulation
10.7.2.2. Drug Delivery
10.7.2.3. Vaccines
10.7.2.4. Medical Device Coating
10.7.2.5. Culture Medium & Stabilizer
10.7.2.6. Diagnostics
10.7.2.7. In Vitro Fertilization
10.8. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
10.9. North America Albumin (as Excipient) Market Forecast, by End-user
10.9.1. Pharmaceutical & Biotechnology Industry
10.9.2. Research Institutes
10.9.3. Others
11. Europe Albumin (as Excipient) Market Analysis
11.1. Europe Albumin (as Excipient) Market Overview
11.2. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
11.3. Europe Albumin (as Excipient) Market Forecast, by Countries/Sub-region
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
11.5. Europe Albumin (as Excipient) Market Forecast, by Product Type
11.5.1. Human Serum Albumin
11.5.2. Recombinant Albumin
11.6. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
11.7. Europe Albumin (as Excipient) Market Forecast, by Application
11.7.1. Human Serum Albumin Applications
11.7.1.1. Drug Formulation
11.7.1.2. Drug Delivery
11.7.1.3. Vaccines
11.7.1.4. Medical Device Coating
11.7.1.5. Culture Medium & Stabilizer
11.7.1.6. Diagnostics
11.7.1.7. In Vitro Fertilization
11.7.2. Recombinant Albumin
11.7.2.1. Drug Formulation
11.7.2.2. Drug Delivery
11.7.2.3. Vaccines
11.7.2.4. Medical Device Coating
11.7.2.5. Culture Medium & Stabilizer
11.7.2.6. Diagnostics
11.7.2.7. In Vitro Fertilization
11.8. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
11.9. Europe Albumin (as Excipient) Market Forecast, by End-user
11.9.1. Pharmaceutical & Biotechnology Industry
11.9.2. Research Institutes
11.9.3. Others
12. Asia Pacific Albumin (as Excipient) Market Analysis
12.1. Asia Pacific Albumin (as Excipient) Market Overview
12.2. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
12.3. Asia Pacific Albumin (as Excipient) Market Forecast, by Countries/Sub-region
12.3.1. Japan
12.3.2. China
12.3.3. India
12.3.4. Australia & New Zealand
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
12.5. Asia Pacific Albumin (as Excipient) Market Forecast, by Product Type
12.5.1. Human Serum Albumin
12.5.2. Recombinant Albumin
12.6. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
12.7. Asia Pacific Albumin (as Excipient) Market Forecast, by Application
12.7.1. Human Serum Albumin Applications
12.7.1.1. Drug Formulation
12.7.1.2. Drug Delivery
12.7.1.3. Vaccines
12.7.1.4. Medical Device Coating
12.7.1.5. Culture Medium & Stabilizer
12.7.1.6. Diagnostics
12.7.1.7. In Vitro Fertilization
12.7.2. Recombinant Albumin
12.7.2.1. Drug Formulation
12.7.2.2. Drug Delivery
12.7.2.3. Vaccines
12.7.2.4. Medical Device Coating
12.7.2.5. Culture Medium & Stabilizer
12.7.2.6. Diagnostics
12.7.2.7. In Vitro Fertilization
12.8. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
12.9. Asia Pacific Albumin (as Excipient) Market Forecast, by End-user
12.9.1. Pharmaceutical & Biotechnology Industry
12.9.2. Research Institutes
12.9.3. Others
13. Latin America Albumin (as Excipient) Market Analysis
13.1. Latin America Albumin (as Excipient) Market Overview
13.2. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
13.3. Latin America Albumin (as Excipient) Market Forecast, by Countries/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
13.5. Latin America Albumin (as Excipient) Market Forecast, by Product Type
13.5.1. Human Serum Albumin
13.5.2. Recombinant Albumin
13.6. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
13.7. Latin America Albumin (as Excipient) Market Forecast, by Application
13.7.1. Human Serum Albumin Applications
13.7.1.1. Drug Formulation
13.7.1.2. Drug Delivery
13.7.1.3. Vaccines
13.7.1.4. Medical Device Coating
13.7.1.5. Culture Medium & Stabilizer
13.7.1.6. Diagnostics
13.7.1.7. In Vitro Fertilization
13.7.2. Recombinant Albumin
13.7.2.1. Drug Formulation
13.7.2.2. Drug Delivery
13.7.2.3. Vaccines
13.7.2.4. Medical Device Coating
13.7.2.5. Culture Medium & Stabilizer
13.7.2.6. Diagnostics
13.7.2.7. In Vitro Fertilization
13.8. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
13.9. Latin America Albumin (as Excipient) Market Forecast, by End-user
13.9.1. Pharmaceutical & Biotechnology Industry
13.9.2. Research Institutes
13.9.3. Others
14. Middle East & Africa Albumin (as Excipient) Market Analysis
14.1. Middle East & Africa Albumin (as Excipient) Market Overview
14.2. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
14.3. Middle East & Africa Albumin (as Excipient) Market Forecast, by Countries/Sub-region
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of MEA
14.4. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
14.5. Middle East & Africa Albumin (as Excipient) Market Forecast, by Product Type
14.5.1. Human Serum Albumin
14.5.2. Recombinant Albumin
14.6. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
14.7. Middle East & Africa Albumin (as Excipient) Market Forecast, by Application
14.7.1. Human Serum Albumin Applications
14.7.1.1. Drug Formulation
14.7.1.2. Drug Delivery
14.7.1.3. Vaccines
14.7.1.4. Medical Device Coating
14.7.1.5. Culture Medium & Stabilizer
14.7.1.6. Diagnostics
14.7.1.7. In Vitro Fertilization
14.7.2. Recombinant Albumin
14.7.2.1. Drug Formulation
14.7.2.2. Drug Delivery
14.7.2.3. Vaccines
14.7.2.4. Medical Device Coating
14.7.2.5. Culture Medium & Stabilizer
14.7.2.6. Diagnostics
14.7.2.7. In Vitro Fertilization
14.8. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
14.9. Middle East & Africa Albumin (as Excipient) Market Forecast, by End-user
14.9.1. Pharmaceutical & Biotechnology Industry
14.9.2. Research Institutes
14.9.3. Others
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis/Ranking, by Company, 2021
15.3. Company Profiles
15.3.1. Albumedix Ltd.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Albumin Therapeutics, LLC (Albumin Bioscience)
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Biotest AG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. CSL Behring (CSL)
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Grifols, S.A.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. HiMedia Laboratories
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. InVitria
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Medxbio Pte Ltd
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Octapharma AG
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. RayBiotech, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. SeraCare Life Sciences
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
15.3.12. Sigma-Aldrich Co. (Merck KGaA)
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. Financial Overview
15.3.12.4. SWOT Analysis
15.3.12.5. Strategic Overview
15.3.13. Takeda Pharmaceutical Company Limited (Shire)
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Portfolio
15.3.13.3. Financial Overview
15.3.13.4. SWOT Analysis
15.3.13.5. Strategic Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us